Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Avicanna Inc. (T:AVCN)

Business Focus: Biotechnology & Medical Research

INK Edge Outlook

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for AVCN within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Mar 04, 2021 13:22 ET
Avicanna Closes Non-Brokered Private Placement Raising $5.6 Million
Avicanna Inc. ("Avicanna" or the "Company") (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of organic and sustainable plant-derived cannabinoid-based products, is...
Read full article
Mar 04, 2021 13:07 ET
IIROC Trade Resumption - AVCN
TORONTO, March 4, 2021 /CNW/ - Trading resumes in:
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
N/A
--
--
Price to Sales - TTM
20.25
18.91
14.69
Price to Book - most recent quarter
2.23
5.38
4.45
Price to Cash Flow per share - TTM
--
15.28
15.66
Price to Free Cash Flow per share - TTM
--
35.44
28.14
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Feb 28, 2021160,23834,816
Feb 15, 2021125,42249,279
Jan 31, 202176,143-9,219
See Short Report

Business Summary

Sector:  Healthcare Industry:  Biotechnology & Medical Research

Avicanna Inc. is a Canada-based biopharmaceutical company. The Company is focused on the research, development, and commercialization of plant-derived cannabinoid-based products for the global consumer, medical, and pharmaceutical market segments. In addition to its developing pharmaceutical pipeline, it has product lines, including Pura H&W and RHO Phyto. Pura H&W is a line of cannabidiol (CBD) consumer derma-cosmetic products. RHO Phyto is a line of medical cannabis products containing varying ratios of CBD and tetrahydrocannabinol (THC). The Company's subsidiary includes Sativa Nativa S.A.S. and Santa Marta Golden Hemp S.A.S.

See business summary

 

Twitter

Search (past week) for $AVCN.CA

  • No tweets found